68Ga-PSMA-617 PET/CT at 1 h after injection | 68Ga-PSMA-617 PET/CT at 3 h after injection | |||||
Different types of PCa | SUV | Range | Median | SUV | Range | Median |
LN metastases (n = 39) | SUVmean 7.1 ± 4.3 | 1.4–22.0 | 6.4 | SUVmean 9.9 ± 2.4 | 2.5–34.1 | 7.7 |
Bone metastases (n = 8) | SUVmean 9.4 ± 7.5 | 3.3–25.6 | 5.9 | SUVmean 16.9 ± 12.5 | 4.5–44.9 | 12.5 |
Local relapses (n = 3) | SUVmean 6.5 ± 0.9 | 5.9–7.5 | 6.2 | SUVmean 7.7 ± 0.6 | 7.2–8.3 | 7.7 |
Primary tumors (n = 3) | SUVmean 7.1 ± 0.4 | 6.8–7.3 | 7.1 | SUVmean 11.7 ± 1.1 | 10.9–12.5 | 11.7 |
LN metastases (n = 39) | SUVmax 12.3 ± 10.3 | 1.4–50.4 | 9.3 | SUVmax 20.4 ± 22.5 | 2.5–84.4 | 12.3 |
Bone metastases (n = 8) | SUVmax 17.8 ± 12.0 | 4.7–43.0 | 13.9 | SUVmax 43.3 ± 24.8 | 12.1–92.6 | 38.6 |
Local relapses (n = 3) | SUVmax 11.1 ± 2.1 | 9.6–13.5 | 10.1 | SUVmax 16.3 ± 0.9 | 15.4–17.1 | 16.4 |
Primary tumors (n = 3) | SUVmax 8.6 ± 3.4 | 4.8–11.4 | 9.5 | SUVmax 12.7 ± 7.5 | 4.1–18.2 | 15.8 |
Data are SUVmean or SUVmax ± SD.